Han.biomedical Inc. (TPEX:6999)
Taiwan · Delayed Price · Currency is TWD 28.10
-0.75 (-2.60%)
At close: Aug 18, 2026
Han.biomedical Market Cap
Han.biomedical has a market cap or net worth of 649.55 million as of August 18, 2026. Its market cap has decreased by -33.70% in one year.
Market Cap
649.55M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.10
ChartMarket Cap Chart
Since July 31, 2024, Han.biomedical's market cap has decreased from 788.04M to 649.55M, a decrease of -17.57%. That is a compound annual growth rate of -9.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 649.55M | -19.71% |
| Dec 31, 2025 | 809.05M | 20.08% |
| Dec 30, 2024 | 673.74M | -14.51% |
| Jul 31, 2024 | 788.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 20.31B |
| Elixiron Immunotherapeutics (Cayman) Limited | 15.37B |
| Intelligene | 7.05B |
| Uwell Biopharma | 6.67B |
| Tripartite Therapeutics | 5.29B |
| Obigen Pharma | 3.80B |
| Pet Pharm Biotech | 2.79B |
| BIONET Therapeutics | 2.10B |